Dysfunctional AV Graft

1

Review clinical trials related to Dysfunctional AV Graft. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Serranator POINT FORCE Registry

The objective of this registry is to collect observational data under local standard of care and evaluate safety and performance of the Serranator® in treatment of peripheral artery disease (PAD), or dysfunctional native or synthetic arteriovenous dialysis fistulae in a real-world scenario. The data and conclusions derived from this study will be used to provide clinical evidence for the clinical evaluation process.

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Cagent Vascular LLCUpdated: May 7, 2026Locations: 19Duration: 1 Day
Eligibility criteria

Subjects intended to be treated with Serranator® for de-novo or restenotic lesio... [+3]

Subjects with any medical condition that would make him/her an inappropriate can... [+1]